Challenges Facing Adverse Drug Reactions Reporting and Counterfeit Drugs Monitoring
Domain:
healthcarePublisher:
Host:
This chapter investigates in a case study the limitations of adverse drug reactions reporting (ADRr) and the challenges facing counterfeit drugs monitoring in the African developing countries with a focus on the Republic of Benin and proposes solutions to improve the adverse drug reporting method and infrastructures as well as the counterfeit drugs monitoring. The study aims at implementing an ADRr system using the m-health technology to overcome the limitations and ease the use of the “yellow card” in the developing world. Furthermore, a real-time notification system is provided to promptly disseminate among the populations any registered and proved ADR.
Similar
Some patient experiences with drugs and adverse drug reactions in an African teaching hospitalAdverse drug reactions to Ivermectin and Albendazole following mass drug administrationsHealthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional studyThe contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative studyPrediction of adverse drug reactions using drug convolutional neural networksIncidence and Predictors of Severe Adverse Drug Reactions among Patients on Antiretroviral Drugs in Harari Regional State, Eastern Ethiopia